Pharmaceutical

Innate shelves lacutamab monotherapy plans in peripheral T cell lymphoma

A combo trial will continue as planned in addition to the biotech’s cutaneous T Cell lymphoma programme.

Mar 24, 2024 - 00:00
Innate shelves lacutamab monotherapy plans in peripheral T cell lymphoma
A combo trial will continue as planned in addition to the biotech’s cutaneous T Cell lymphoma programme.
Read the original article

Tags:

Previous Article

Pharmaceutical consulting companies, pharmaceutical training and other developme...

Next Article

Chinook Therapeutics files patent for improving kidney function in a subject

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Be Bio raises $82m to advance haemophilia B gene therapy to Phase I/II trial

Be Bio raises $82m to advance haemophilia B gene therap...

Oct 24, 2024

Signal: Serum Institute of India plans to increase global reach

Signal: Serum Institute of India plans to increase glob...

Oct 7, 2023

Scientists, going on a bear hunt, find a potential way to treat deadly blood clots

Scientists, going on a bear hunt, find a potential way ...

Apr 13, 2023